GDNF and Parkinson disease: Similarly, there was a discordance between dopaminergic PET measures, namely 18F-DOPA, and clinical outcomes in trials of fetal nigral grafting and intraputaminal glial cell line-derived neurotrophic factor (GDNF) in PD patients [225,226].